EyeSonix

New Prototype now down from 45 lbs to 5 lbs!!!

Our Business

EyeSonix is developing a transformative method of treating glaucoma.  The use of low power ultrasound to treat glaucoma has the potential to offer neuroprotection to halt or reduce damage to the optic nerve beyond the decrease in intraocular pressure. 

Our Team: 

Donald Schwartz  MD MPA   CEO  President

 

2012 Connect Healthcare Innovation Venture Roundtable

2013  Winner: Biocom Med Device and Diagnostics EXPO 2013

 2013 Awarded Grant to continue Clinical Studies from Western Glaucoma Foundation

2014 Presented @ Ophthalmology Innnovation Summit/ASCRS  in Boston as Innovative Private Company  see presentation:       http://ois.net/eyesonix/

Presented at Royal Australian and New Zealand Congress of Ophthalmology Nov 2014

Presented at Glaucoma Research Foundation  New Horizons Forum Feb 2015

Nominee for LA Business Journal 2015 Patrick Soon-Shiong Innovation Awards

Presented at the 1st International Micro-invasive Glaucoma Surgery Symposium in Changsha, Hunan, China  November 2016